(Q51527679)

6 April 2018

title

Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal. (English)

1 reference

6 April 2018

author name string

Bowers MB Jr

1

1 reference

6 April 2018

Malison RT

2

1 reference

6 April 2018

Seibyl JP

3

1 reference

6 April 2018

Kosten TR

4

1 reference

6 April 2018

language of work or name

English

0 references

publication date

1 February 1998

1 reference

6 April 2018

published in

Biological Psychiatry

1 reference

6 April 2018

volume

43

1 reference

6 April 2018

issue

4

1 reference

6 April 2018

page(s)

278-281

1 reference

6 April 2018

Effects of haloperidol and probenecid on plasma and CSF dopamine metabolites in the rhesus monkey (Macacca Mulatta)

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900293-X

Plasma homovanillic acid levels and subtyping of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900293-X

Plasma homovanillic acid as a predictor of response to neuroleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900293-X

Plasma homovanillic acid concentration and the severity of schizophrenic illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900293-X

Cocaine abuse treatment. Open pilot trial with desipramine and lithium carbonate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900293-X

Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900293-X

Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900293-X

The determination of a brain arteriovenous difference for 3-methoxy-4-hydroxyphenethyleneglycol (MHPG).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900293-X

Clinical ratings and plasma HVA during cocaine abstinence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900293-X

Plasma catecholamine metabolites in subtypes of major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900293-X

Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900293-X

Dopaminergic responsivity during cocaine abstinence: a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900293-X

Noradrenergic dysregulation during discontinuation of cocaine use in addicts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900293-X

Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900293-X

Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900293-X

Plasma and CSF HVA before and after pharmacological treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900293-X

Intravenous cocaine: psychiatric effects, biological mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900293-X

10.1016/S0006-3223(97)00293-X

7 January 2021

Identifiers

DOI

1 reference

6 April 2018

1 reference

6 April 2018